Oppenheimer Sticks to Its Hold Rating for Lemonade (LMND)
Oppenheimer analyst maintained a Hold rating on Lemonade yesterday. The company’s shares closed yesterday at $57.31.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to Oppenheimer, Lemonade also received a Hold from Piper Sandler’s John Barnidge in a report issued on February 19. However, yesterday, Truist Financial maintained a Buy rating on Lemonade (NYSE: LMND).
Based on Lemonade’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $194.5 million and a GAAP net loss of $37.5 million. In comparison, last year the company earned a revenue of $136.6 million and had a GAAP net loss of $67.7 million
Based on the recent corporate insider activity of 79 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LMND in relation to earlier this year. Most recently, in December 2025, Debra Schwartz, a Director at LMND sold 4,200.00 shares for a total of $351,078.00.
Read More on LMND:
Disclaimer & DisclosureReport an Issue
- Lemonade: Strong Growth Momentum but Unproven Path to Sustainable Profitability Supports Hold Rating
- Lemonade price target lowered to $65 from $85 at Piper Sandler
- Unusually active option classes on open February 19th
- Options Volatility and Implied Earnings Moves Today, February 19, 2026
- Lemonade sees 2026 revenue $1.19B-$1.19B, consensus $1.16B
